NCT04405128Completed
Brain TV (Tissue Velocimetry) for Emergency Assessment of Suspected Stroke
Source: ClinicalTrials.gov · Last updated 20 Sept 2024
Brief summary (registry, in English)
This study uses a Doppler ultrasound technique being developed at the University of Leicester called \"Brain Tissue Velocimetry\" (Brain TV), to investigate brain tissue motion over the cardiac cycle.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 102 (actual)
- First submitted
- 20 May 2020
- Start date
- Aug 2019
- Primary completion date
- Jan 2023
- Lead sponsor
- University of Leicester
- Diseases
- Stroke
- NCT number
- NCT04405128
What you commit to
- Study type: Observational
- Participants enrolled: 102
- From Aug 2019 to the primary completion date, Jan 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with pre-existing chronic brain conditions that may make affect informed consent, such as severe learning difficulties, dementia, or Alzheimer's disease, will be excluded.
Other
- Unable (in the investigators' opinion), or unwilling, to comply with the study requirements.
Who the study is looking for
- Participant (or consultee) is willing and able to give informed consent (or assent) for participation in the study.
- Adult, aged 18 years or over.
- Suspected stroke (any severity and any stroke type).
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Leicester Coordinator of this site? Confirm its status | Leicester | United Kingdom | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.